Sign in to continue:

Wednesday, February 11th, 2026

Sembcorp Industries to Boost Earnings with Strategic Acquisition of Senoko Energy Stake

Date: 18 September 2024
Broker: Maybank Research Pte Ltd


Strategic Acquisition of Senoko Energy Stake

Sembcorp Industries (SCI) and its wholly-owned subsidiary, Sembcorp Utilities, have entered into a sale and purchase agreement with Engie Global Developments (Engie). Under this agreement, SCI will acquire a 30% interest in Senoko Energy from Engie, a major supplier of electricity in Singapore. This acquisition will be funded through SCI’s internal cash resources and/or external borrowings.

Significance of the Acquisition

Senoko Energy plays a crucial role in Singapore’s electricity supply. This acquisition is seen as complementary to SCI’s existing portfolio of energy assets. By adding Senoko Energy to its holdings, SCI will enhance its capability to support Singapore’s energy transition. This strategic move aligns with Singapore’s broader energy objectives and boosts SCI’s position within the energy sector.

Regulatory and Shareholder Approvals

The deal is subject to several conditions. It requires regulatory approval from the Energy Market Authority of Singapore. Additionally, it depends on the exercise or waiver of pre-emption rights from the other shareholders of Senoko Energy. The transaction is expected to be completed by the fourth quarter of 2024.

Earnings Impact

Upon completion, the acquisition is anticipated to be accretive to SCI’s earnings. This means that SCI’s overall financial performance will improve as a result of this transaction, further solidifying its strong position within the energy sector.

Shanghai Pharmaceuticals (601607.SS) Stock Analysis 2025: Buy Rating, Growth Prospects & Financial Review

OCBC Investment Research Report Date: 15 September 2025 Shanghai Pharmaceuticals: Navigating Industry Headwinds, Accelerating Innovation, and Securing Market Leadership Executive Summary Shanghai Pharmaceuticals Holding Co. Ltd. (SPH), one of China’s top three drug distributors...

UMS Holdings Q3 Earnings Miss: Outlook Improves, Upgraded to HOLD

UMS Holdings 3Q24 Financial Analysis UMS Holdings 3Q24 Financial Analysis Date: November 12, 2024 Broker: Maybank Research Pte Ltd Introduction UMS Holdings, a key player in the precision engineering industry, faced a challenging third...

Netlink Trust Reports Strong H1 FY25 Results: 2.68 Cents DPU and 5.8% Dividend Yield

Comprehensive Analysis of Listed Companies – November 2024 Comprehensive Analysis of Listed Companies – November 2024 Broker: Lim & Tan Securities Date: November 5, 2024 Overview of Financial Markets On a day where the...